The predictive value of 3D transvaginal sonography including Power Doppler in the evaluation of fibroid growth, and as a predictor of fibroid response to GnRHa therapy.
Recruiting
- Conditions
- terine Fibroids, growth, power doppler
- Registration Number
- NL-OMON19987
- Lead Sponsor
- Department of obstetrics and gynaecology VUMC
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Women with at least one and maximum three fibroids, without medication or with the intention to start with Lucrin.
Exclusion Criteria
1. More than 3 fibroids;
2. Surgery of the fibroid within 3 months.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome is percentage change in fibroid volume and change in VI parameters after 3, 6 and 12 months.
- Secondary Outcome Measures
Name Time Method Secondary outcome is change in UFS score (fibroid specific QOL), EQ-5D score and PBAC score (validated menstrual chart).